Key result
Increased leisure-time physical activity over 3 months of breast cancer therapy was associated with a decreased likelihood of treatment-induced cardiac dysfunction (OR 0.98; 95% CI 0.97-0.998).
Why the study?
Cancer treatment increases cardiovascular disease risk, but physical activity may prevent cardiovascular disease, prompting examination of whether greater activity preserves exercise capacity and cardiac function during therapy.
Does physical activity prevent declines in exercise capacity and cardiac function in women undergoing breast cancer therapy?
Observational (n=349)
Does physical activity prevent declines in exercise capacity and cardiac function in women undergoing breast cancer therapy?
Maintaining physical activity during breast cancer therapy is associated with preserved exercise capacity and attenuated declines in cardiac function.
Answers are grounded in this paper and cite their sources.
May support activity counseling during breast cancer therapy; hypothesis-generating and requires randomized confirmation.
Cancer treatment increases cardiovascular disease risk, but physical activity (PA) may prevent cardiovascular disease. This study examined whether greater PA was associated with better submaximal exercise capacity and cardiac function during cancer therapy. Participants included 223 women with stage I to III breast cancer (BC) before and 3 months after undergoing treatment and 126 control participants. Leisure-time PA (LTPA) was reported using the Godin-Shephard LTPA questionnaire. Cardiac function was assessed by cardiac magnetic resonance. Submaximal exercise capacity was determined by 6-minute walk distance. BC participants reported similar baseline LTPA scores (24.7; 95% CI: 21.7-28.0) as control participants (29.4; 95% CI: 25.0-34.2). The BC group declined to 16.9 (95% CI: 14.4-19.6) at 3 months relative to 30.8 (95% CI: 26.2-35.8) in control participants. Among BC participants, more LTPA was related to better exercise capacity (β ± SE: 7.1 ± 1.6; 95% CI: 4.0-10.1) and left ventricular (LV) circumferential strain (−0.16 ± 0.07; 95% CI: −0.29 to −0.02). Increased LTPA over the 3 months was associated with decreased likelihood of treatment-induced cardiac dysfunction according to LV circumferential strain classifications (OR: 0.98; 95% CI: 0.97-0.998). BC participants reporting insufficient LTPA according to PA guidelines exhibited deteriorations in exercise capacity (adjusted mean difference ± SE: −29 ± 10 m; P = 0.029), LV end-systolic volume (5.8 ± 1.3 mL; P < 0.001), LV ejection fraction (−3.2 ± 0.8%; P = 0.002), and LV circumferential strain (2.5 ± 0.5%; P < 0.001), but BC participants meeting LTPA guidelines did not exhibit these adverse changes. PA declined during BC therapy; however, PA participation was associated with attenuated declines in exercise capacity and cardiac function that are often observed in this population. (Understanding and Predicting Breast Cancer Events After Treatment [WF97415 UPBEAT]; NCT02791581)
No takes yet. Share an insight, caveat, or question.
Bellissimo et al. (2023) conducted an observational in Stage I to III breast cancer (n=349). Leisure-time physical activity (LTPA) vs. Insufficient LTPA was evaluated on Treatment-induced cardiac dysfunction according to LV circumferential strain classifications (OR 0.98, 95% CI 0.97-0.998). Increased leisure-time physical activity over 3 months of breast cancer therapy was associated with a decreased likelihood of treatment-induced cardiac dysfunction (OR 0.98; 95% CI 0.97-0.998).
Synapse has enriched 10 related papers. Consider them for comparative context: